Clinical Trials · NCT01755182

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors

TerminatedPhase 3Octreotide (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
National Cancer Institute, Naples
Enrollment
1
Start date
Jul 2013
Locations
12 sites, Italy
Primary endpoint
progression free survival
View Octreotide compound reference